EMERYVILLE, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2018, after the market close, and will host a corporate update conference call and webcast on Thursday, February 28, 2019, at 4:30 PM Eastern Time.
| Conference Call Details | |
| Thursday, February 28 @ 4:30 PM Eastern Time/1:30 PM Pacific Time | |
| Toll Free: | 877-407-9716 |
| International: | 201-493-6779 |
| Conference ID: | 13687457 |
| Webcast: | http://public.viavid.com/index.php?id=133233 |
| Replays available through March 14: | |
| Domestic: | 844-512-2921 |
| International: | 412-317-6671 |
| Replay PIN: | 13687457 |
About Zogenix
Zogenix is a global pharmaceutical company committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases. For more information, visit www.zogenix.com.
CONTACTS:
Zogenix
Melinda Baker
Senior Director, Corporate Communications
ir@zogenix.com
Investors
Andrew McDonald
Founding Partner, LifeSci Advisors LLC
+1 (646) 597-6987 | Andrew@lifesciadvisors.com